You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adult primary hepatocellular carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Metastatic Extrahepatic Bile Duct Cancer Trial in

Active, not recruiting
  • Adult Primary Hepatocellular Carcinoma
  • +6 more
  • PET scan
  • +2 more
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jul 21, 2022

Adult Primary Hepatocellular Carcinoma, Localized Resectable Adult Primary Liver Cancer, Localized Unresectable Adult Primary

Suspended
  • Adult Primary Hepatocellular Carcinoma
  • +3 more
  • sorafenib tosylate
  • +2 more
  • Birmingham, Alabama
  • +20 more
Aug 29, 2022

Melanoma, Non-small Cell Lung Carcinoma (NSCLC), Renal Cell Carcinoma (RCC) Trial in Gainesville, Jacksonville (LITT +

Recruiting
  • Melanoma
  • +14 more
  • LITT + Pembrolizumab
  • Gainesville, Florida
  • +1 more
Aug 22, 2022

Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Advanced Adult Hepatocellular Carcinoma Trial in

Completed
  • Adult Primary Hepatocellular Carcinoma
  • +4 more
  • Chinese herbal formulation PHY906
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Jan 26, 2021

Hepatocellular Carcinoma Trial in Hangzhou (Fruquintinib, Sintilimab, Transcatheter arterial chemoembolization(TACE))

Recruiting
  • Hepatocellular Carcinoma
  • Hangzhou, Zhejiang, China
    Guoliang Shao
Aug 1, 2023

Primary Hepatocellular Carcinoma Trial (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)), camrelizumab for

Not yet recruiting
  • Primary Hepatocellular Carcinoma
  • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
  • camrelizumab for Injection
  • (no location specified)
Nov 13, 2023

Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer

Recruiting
  • Adult Primary Hepatocellular Carcinoma
  • +3 more
  • yttrium Y 90 glass microspheres
  • laboratory biomarker analysis
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Sep 17, 2020

Primary Hepatocellular Carcinoma, Portal Vein Thrombosis Trial (Recombinant human adenovirus type 5 + TACE)

Not yet recruiting
  • Primary Hepatocellular Carcinoma
  • Portal Vein Thrombosis
  • Recombinant human adenovirus type 5 + TACE
  • (no location specified)
May 14, 2023

Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer Trial in

Active, not recruiting
  • Adult Primary Hepatocellular Carcinoma
  • +2 more
  • sorafenib tosylate
  • stereotactic body radiation therapy
  • Berkeley, California
  • +50 more
Nov 17, 2022

Adult Primary Liver Cancer, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer Trial in

Recruiting
  • Adult Primary Liver Cancer
  • +2 more
  • TSR-022 and TSR-042
  • Honolulu, Hawaii
    University of Hawaii
Sep 22, 2021

Hepatocellular Carcinoma Trial (Livmoniplimab, Budigalimab, Durvalumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Oct 26, 2023

Advanced Hepatocellular Carcinoma Trial in Guangzhou (drug, procedure, radiation)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Feb 7, 2023

Single-cell RNA Sequencing Resolves Regulatory Role of HBV on

Recruiting
  • HBV
  • Primary Liver Cancer
  • HBV DNA Sequencing
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Dec 22, 2022

Unresectable Hepatocellular Carcinoma (HCC) Trial in Milano, Rozzano, Barcelona (NMS-01940153E)

Recruiting
  • Unresectable Hepatocellular Carcinoma (HCC)
  • Milano, Italy
  • +2 more
Dec 2, 2022

Hepatocellular Carcinoma Trial (Donafenib + Tislelizumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Donafenib + Tislelizumab
  • (no location specified)
Sep 15, 2022

Hepatocellular Carcinoma Trial in United States (AZD5851)

Not yet recruiting
  • Hepatocellular Carcinoma
  • AZD5851
  • Duarte, California
  • +9 more
Oct 12, 2023

Hepatocellular Carcinoma, Hepatoma, Liver Cancer, Adult Trial in Charlotte (Transarterial embolization, Microwave Ablation)

Terminated
Has Results
  • Hepatocellular Carcinoma
  • +4 more
  • Transarterial embolization
  • Microwave Ablation
  • Charlotte, North Carolina
    Carolinas Medical Center
Apr 20, 2022

Hepatocellular Carcinoma, Hepatocellular Cancer, Metastatic Pancreatic Cancer Trial run by the NCI (nivolumab, tadalafil, oral

Completed
  • Hepatocellular Carcinoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Hepatocellular Carcinoma, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancers Trial (ABBV-400)

Not yet recruiting
  • Hepatocellular Carcinoma
  • +6 more
  • (no location specified)
Oct 10, 2023

Hepatocellular Carcinoma Trial (Propofol, Sevoflurane)

Recruiting
  • Hepatocellular Carcinoma
  • Kaohsiung, Taiwan
    Kaohsiung Medical University Chung-Ho Memorial Hospital
Nov 28, 2022

Advanced Hepatocellular Carcinoma (HCC), Gastric Cancer Metastatic to Liver, Colorectal Cancer Metastatic to Liver Trial in

Recruiting
  • Advanced Hepatocellular Carcinoma (HCC)
  • +2 more
  • Duarte, California
  • +2 more
Aug 29, 2022

Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Houston (SD-101, Pembrolizumab, Nivolumab)

Recruiting
  • Hepatocellular Carcinoma
  • Intrahepatic Cholangiocarcinoma
  • New York, New York
  • +3 more
Oct 19, 2022

Advanced Adult Hepatocellular Carcinoma Trial in Chicago, Ann Arbor, Dallas (Cabozantinib)

Recruiting
  • Advanced Adult Hepatocellular Carcinoma
  • Chicago, Illinois
  • +3 more
Aug 15, 2022

Hepatocellular Carcinoma Trial in Taipei City, Taipei (Para-Toluenesulfonamide)

Recruiting
  • Hepatocellular Carcinoma
  • Taipei City, Taiwan
  • +2 more
Mar 28, 2022

Solid Tumor, Adult, Triple Negative Breast Cancer, Colorectal Cancer Trial in Scottsdale, La Jolla, Stanford (CRX100 suspension

Recruiting
  • Solid Tumor, Adult
  • +6 more
  • CRX100 suspension for infusion
  • Scottsdale, Arizona
  • +2 more
Jul 26, 2022